Casnate, Italy

Vijay Kumar

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Vijay Kumar: Innovating Biological Activity Assessment

Introduction

Vijay Kumar, an accomplished inventor based in Casnate, Italy, is known for his significant contributions to the field of biochemistry and pharmaceutical sciences. With a total of eight patents to his name, he has focused his research on innovative methods that enhance the understanding and application of defibrotide, a drug used in various therapeutic contexts.

Latest Patents

Among his notable achievements is the recent patent for an "Euglobulin-based method for determining the biological activity of defibrotide." This innovative method involves bringing defibrotide into contact with mammalian euglobulin and a substrate specific for plasmin. The reaction produces a measurable product, allowing for the assessment of defibrotide's biological activity. The liquid formulations of defibrotide disclosed in the patent are aimed at providing water solutions with a defined biological activity, specifically ranging from 25 to 35 IU/mg, with an optimal range from 28 to 32 IU/mg.

Career Highlights

Vijay Kumar's career has been marked by his work at prominent companies such as Gentium S.r.l. and Danisco A/S. His tenure at these organizations has allowed him to further his research and application of biotechnological innovations, particularly those related to therapeutic agents.

Collaborations

Throughout his career, Kumar has collaborated with esteemed colleagues, including Terenzio Ignoni and Khalid Islam. These partnerships have undoubtedly enriched his research endeavors and contributed to the advancement of innovative biotechnological solutions.

Conclusion

In conclusion, Vijay Kumar is a remarkable inventor whose work in developing methodologies to assess the biological activity of defibrotide has the potential to impact the pharmaceutical industry positively. His dedication to innovation and collaboration underscores the importance of continued research in the medical field, aiming for breakthroughs that can enhance treatment and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…